Layer 1

Candesartan 8mg among final 16 price concessions announced for April

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 16 items for April 2019 prescriptions.

An initial 30 prices for the month were announced on April 16, followed by a further 25 prices on April 18.

Drug
Strength
Form
Price
Bumetanide
1mg
tablets (28)
£1.39
Candesartan
8mg
tablets (28)
£2.30
Co-careldopa
25mg/100mg
tablets (100)
£10.00
Finasteride
5mg
tablets (28)
£1.34
Irbesartan
75mg
tablets (28)
£2.18
Irbesartan
150mg
tablets (28)
£3.16
Nebivolol
5mg
tablets (28)
£5.29
Pantoprazole
20mg
tablets (28)
£1.73
Pantoprazole
40mg
tablets (28)
£3.65
Quetiapine
200mg
tablets (60)
£12.78
Quetiapine
300mg
tablets (60)
£9.99
Riluzole
50mg
tablets (56)
£115.68
Risedronate sodium
35mg
tablets (4)
£7.27
Telmisartan
80mg
tablets (28)
£6.62
Tolbutamide
500mg
tablets (28)
£22.70
Topiramate
50mg
tablets (60)
£12.27

Earlier this month (April 9), the Pharmaceutical Services Negotiating Committee told C+D it is becoming “increasingly concerned” about the impact of generics supply issues, after a record 96 price concessions were agreed for March.

3 Comments
Question: 
Do these prices reflect the ones you have paid in April?

N O, Pharmaceutical Adviser

Why not C&D do an investigational article to get to the bottom of this. I am sure there will be many indepedent pharmacies, who will be happy to share the details of prices paid (actual Invoices) against the NCSO prices??

N patel , Non Pharmacist Branch Manager

c&d wont do any investigation of this sort...dont want to upset their incompetent pals at the psnc 

N patel , Non Pharmacist Branch Manager

prices plucked out the thin air and nothing like wht we are paying in the real world,,,or so it feels like

Job of the week

Pharmacist Manager
Wellingborough, Northamptonshire
Competitive